3Downen M, Amaral TD, Hua LL, et al. Neuronal death in cytokine-activated primary human brain cell culture: role of·tumor necrosis factor-alpha. Glia, 1999, 28(2): 114-127
4Suzumura A, Ito A, Yoshikowa M, et al. Ibudilast suppresses TNF alpha production by glial cells functioning mainly as type Ⅲ phosphodiesterast inhibitor in the CNS. Brain Res, 1999, 837(1-2): 203-212
5Connor TJ, Song C, Leonard BE, et al. Anassessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factoralpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience, 1998, 84(3): 923-933
6Knoblach SM, Fan L, Faden AI. Early neuronal expression of tumor necrosisfactor-alpha afterexperi mental brain injury contributes toneurologi calimpairment. J Neuroimmunol, 1999, 95(1-2): 115-125
7Yang GY, Schieike GP, Gong C, et at. Expression of tumor necrosis factor-alpha and intercellular adhesion molecule-1 after focal cerebral ischemia in interleukin-1beta converting enzyme deficient mice. J Cereb Blood Flow Metab, 1999, 19(10): 1109-1117
8Yang GY, Gong C, Qin Z, et at. Tumornocrosis factor alpha expression produces increased blood-brain barrier peremeability following temporary focal cerebral ischemia in mice. Brain Res Mol Brain Res, 1999, 69(1): 135-143
9Zhu DY, Li R, Liu GQ, et at. Tumornecrosis factor alpha Enhances the cytotoxicity induced by nitric oxide in cultured cerebral endothelial cells. Life Sci, 2000, 66(14): 1325-1335
10Yu AC, Lau LT. Expression of interleukin-1alpha, tumor necrosis factor alpha and interteukin-6 genes in astrocytes under ischemic injury. Neurochem Int, 2000, 36(4-5): 369-377
1LUGER T J, LORENZ I H, GRABNER-WEISS C, et al. Effect of fluvoxamine on sufentanil antinociception and tolerance under chronic intravenous infusion in rats [ J ]. Pharmacol Toxicol, 1999,85 ( 6 ) : 263 - 268.
2YOGESWARI P, RAGAVENDRAN J V, S. D. Neuropathic pain : strategies in drug discovery and treatment [ J ]. Expert Opin Drug Discov, 2007, 2 (2) :169 - 184.
3NITANDA A, YASUNAMI N, TOKUMO K, et al. Contribution of the peripheral 5-HT2A receptor to mechanical hyperalgesia in a rat model of neuropathic pain [ J ]. Neurochem Int, 2005,47 ( 6 ) :394 - 400.
4OKAMOTO K, IMBE H, TASHIRO K, et al. The role of peripheral 5-HT2A and 5-HT1A receptors on the orofacial formalin test in rats with persistent temporomandibular joint inflammation [ J ]. Neuroscience,2005,130 ( 2 ) :465 - 474.
5SASAKI M, OBATA H, KAWAHARA K, et al. Peripheral 5-HT2A receptor antagonism attenuates primary thermal hyperalgesia and secondary mechanical allodynia after thermal injury in rots [ J ].Pain, 2006, 122(1/2) :130 - 136.
6NAKAJIMA K, OBATA H, ITO N, et ai. The nociceptive mechanism of 5-hydroxytryptamine released into the peripheral tissue in acute inflammatory pain in rats[J]. Eur J Pain,2009,13(5) :441 -447.
7KESIM M, DUMAN EN, KADIOGLU M, et al. The different roles of 5-HT2 and 5-HT3 receptors on antinociceptive effect of paroxetine in chemical stimuli in mice[ J]. J Pharmacol Sci ,2005,97 ( 1 ) :61 - 66.
8ROELOF W, AXEL S, JAN-WILLEM T, et al. Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition :WO,2006/ 061377 [ P]. 2006 - O6 - 15.
9ZHAO G, ZHANG S Y, ZHENG X W, et al. Bakuchiol analogs inhibit monoamine transporters and regulate monoaminergic functions [ J ]. Biochem Pharmaco1,2008,75 ( 9 ) : 1835 - 1847.
10RAHHIMIAN R, HRDINA P D. Possible role of protein kinase C in regulation of 5-hydroxytrptamine 2A receptors in rat brain[J]. Can J Physiol Pharmacol, 1995,73 (12) : 1686 - 1691.
